125 related articles for article (PubMed ID: 23707252)
1. Controlled release of morphine from a poloxamer 407 gel.
Jansen MM; Verzijl JM; Burger DM; Hekster YA
Int J Pharm; 2013 Aug; 452(1-2):266-9. PubMed ID: 23707252
[TBL] [Abstract][Full Text] [Related]
2. In vitro characterization of a formulation of butorphanol tartrate in a poloxamer 407 base intended for use as a parenterally administered slow-release analgesic agent.
Laniesse D; Smith DA; Knych HK; Mosley C; Guzman DS; Beaufrère H
Am J Vet Res; 2017 Jun; 78(6):677-687. PubMed ID: 28541144
[TBL] [Abstract][Full Text] [Related]
3. High encapsulation efficiency of poloxamer-based injectable thermoresponsive hydrogels of etoposide.
Soni G; Yadav KS
Pharm Dev Technol; 2014 Sep; 19(6):651-61. PubMed ID: 23879721
[TBL] [Abstract][Full Text] [Related]
4. Influence of oleic acid on the rheology and in vitro release of lumiracoxib from poloxamer gels.
Moreira TS; de Sousa VP; Pierre MB
J Pharm Pharm Sci; 2010; 13(2):286-302. PubMed ID: 20816013
[TBL] [Abstract][Full Text] [Related]
5. Development and characterisation of modified poloxamer 407 thermoresponsive depot systems containing cubosomes.
Kojarunchitt T; Hook S; Rizwan S; Rades T; Baldursdottir S
Int J Pharm; 2011 Apr; 408(1-2):20-6. PubMed ID: 21272624
[TBL] [Abstract][Full Text] [Related]
6. Sustained release of lidocaine from Poloxamer 407 gels.
Ricci EJ; Lunardi LO; Nanclares DM; Marchetti JM
Int J Pharm; 2005 Jan; 288(2):235-44. PubMed ID: 15620863
[TBL] [Abstract][Full Text] [Related]
7. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
[TBL] [Abstract][Full Text] [Related]
8. Poloxamer-hydroxyethyl cellulose-α-cyclodextrin supramolecular gels for sustained release of griseofulvin.
Marcos X; Pérez-Casas S; Llovo J; Concheiro A; Alvarez-Lorenzo C
Int J Pharm; 2016 Mar; 500(1-2):11-9. PubMed ID: 26795192
[TBL] [Abstract][Full Text] [Related]
9. A thermosensitive morphine-containing hydrogel for the treatment of large-scale skin wounds.
Heilmann S; Küchler S; Wischke C; Lendlein A; Stein C; Schäfer-Korting M
Int J Pharm; 2013 Feb; 444(1-2):96-102. PubMed ID: 23352858
[TBL] [Abstract][Full Text] [Related]
10. The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle.
Sherif S; Bendas ER; Badawy S
Eur J Pharm Biopharm; 2014 Feb; 86(2):251-9. PubMed ID: 24056055
[TBL] [Abstract][Full Text] [Related]
11. Assessment of release kinetics, stability and polymer interaction of poloxamer 407-based thermosensitive gel of interleukin-1 receptor antagonist.
Akash MS; Rehman K; Sun H; Chen S
Pharm Dev Technol; 2014 May; 19(3):278-84. PubMed ID: 23506246
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide.
Erfani Jabarian L; Rouini MR; Atyabi F; Foroumadi A; Nassiri SM; Dinarvand R
Eur J Pharm Sci; 2013 Jan; 48(1-2):87-96. PubMed ID: 23131800
[TBL] [Abstract][Full Text] [Related]
13. Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation.
Cafaggi S; Russo E; Caviglioli G; Parodi B; Stefani R; Sillo G; Leardi R; Bignardi G
Eur J Pharm Sci; 2008 Sep; 35(1-2):19-29. PubMed ID: 18598763
[TBL] [Abstract][Full Text] [Related]
14. Influence of additives on a thermosensitive hydrogel for buccal delivery of salbutamol: relation between micellization, gelation, mechanic and release properties.
Zeng N; Dumortier G; Maury M; Mignet N; Boudy V
Int J Pharm; 2014 Jun; 467(1-2):70-83. PubMed ID: 24699353
[TBL] [Abstract][Full Text] [Related]
15. Chemical characterization with XPS of the surface of polymer microparticles loaded with morphine.
Morales ME; Ruiz MA; Oliva I; Oliva M; Gallardo V
Int J Pharm; 2007 Mar; 333(1-2):162-6. PubMed ID: 17074455
[TBL] [Abstract][Full Text] [Related]
16. PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors.
Parajó Y; d'Angelo I; Horváth A; Vantus T; György K; Welle A; Garcia-Fuentes M; Alonso MJ
Eur J Pharm Sci; 2010 Dec; 41(5):644-9. PubMed ID: 20869438
[TBL] [Abstract][Full Text] [Related]
17. Development and in-vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur.
Zhang L; Parsons DL; Navarre C; Kompella UB
J Control Release; 2002 Dec; 85(1-3):73-81. PubMed ID: 12480313
[TBL] [Abstract][Full Text] [Related]
18. Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity.
Jones DS; Bruschi ML; de Freitas O; Gremião MP; Lara EH; Andrews GP
Int J Pharm; 2009 May; 372(1-2):49-58. PubMed ID: 19429268
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid on the urokinase sustained release with a hydrogel system composed of poloxamer 407: HA/P407 hydrogel system for drug delivery.
Hsieh HY; Lin WY; Lee AL; Li YC; Chen YJ; Chen KC; Young TH
PLoS One; 2020; 15(3):e0227784. PubMed ID: 32160196
[TBL] [Abstract][Full Text] [Related]
20.
Hemelryck SV; Dewulf J; Niekus H; van Heerden M; Ingelse B; Holm R; Mannaert E; Langguth P
Int J Pharm X; 2019 Dec; 1():100016. PubMed ID: 31517281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
